4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-22-023741
Options or other derivatives
- EVP, Chief Financial Officer acquired 93,515 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Schneyer Mark C. EVP, Chief Financial Officer | 2022-04-05 | Grant or award · Stock Options (Right to Buy) | +72,414 | 72,414 | D | ||
| Schneyer Mark C. EVP, Chief Financial Officer | 2022-04-05 | Grant or award · Restricted Stock Units | +21,101 | 21,101 | D | ||
Loading xslF345X03/doc4.xml…